ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

About ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G) is an open-ended equity mutual fund offered by ICICI Prudential Mutual Fund. The scheme invests primarily in Sector/Theme - Pharma & Health equity and equity-related instruments in accordance with SEBI’s classification, with the objective of achieving capital appreciation over the long term.

 

The fund follows a structured investment approach based on fundamental and quantitative research, with portfolio construction guided by a disciplined risk return framework focusing on high quality stocks. It seeks to align investments with prevailing market conditions while adhering to defined risk management practices.

Investment Objective of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

As an open-ended scheme, investors may redeem or subscribe units at the NAV of ₹38.00 as of 22 Jan 2026 at the time of the transaction. The scheme is designed for investors with a long-term investment horizon who are comfortable with high risk, and it will form a part of a diversified investment portfolio.

Who should invest?

This scheme may be suitable for investors seeking long term capital appreciation with a long-term investment horizon. It is appropriate for those comfortable with high market risk and aiming to achieve wealth through equity investments. Investors should ensure the scheme aligns with their financial goals, risk appetite, and overall investment plan.

Benefits of Investing in ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

Key advantages include:

1. Professional management: Handled by experienced fund managers
2. Diversification: Exposure to multiple securities reduces risk
3. Liquidity: Easy to buy and redeem (subject to exit loads)
4. Accessibility: Can start investing with small amounts
5. Tax efficiency: If redeemed within 12 months, short-term capital gains (STCG) will apply and will be taxed at 20%. If redeemed after 12 months, long-term capital gains (LTCG) will apply and will be taxed at 12.5%.

Things to Consider Before Investing

Before investing in Sector/Theme - Pharma & Health mutual funds, investors should evaluate:

• Investment objective and time horizon
• Risk tolerance
• Past performance (not a guarantee of future returns)
• Exit load and taxation

Choosing funds that align with your financial goals is more important than chasing short-term returns.

Conclusion

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G) is suitable for investors looking to create wealth while maintaining high risk. Understanding how these funds work, their risks, and their role in a portfolio can help investors make informed investment decisions aligned with their financial goals.